Sustainable and scalable processes in mining and metal transformation are key to responding to the climate change challenges of the 21stcentury. Join MIT researchers and MIT spun-out startups to hear the latest research on Resources Extraction Technologies, and what future trends we can expect in the metal processing industry.
Tailings – what’s left after mined ores are fully processed – is today a global liability. But there are tens of billions of dollars of material value tied up in those tailings. Why not turn them into a revenue opportunity? MIT researchers, and newly spun-out startup companies, are hard at work on inventing, developing, and scaling up technologies that will enable this transition. Join us on November 18th to learn more about this impactful work!
Over the past decade, research on the development of multi-cellular engineered living systems has produced technologies and capabilities that are now positioned to facilitate a fundamental understanding of disease processes and can help to identify innovative therapeutic strategies. Globally, while many labs are engaged in the development of new and more sophisticated organ models for drug discovery and screening, there is an urgent need to disrupt the way drugs are currently developed. Our vision is to humanize drug development based on a new approach that integrates microphysiological system models of disease and enhanced model control/interrogation, with modern systems biology and systems immunology. This is the focus of Living Machines, one of five threads in the New Engineering Education Transformation (NEET) program to reimagine engineering education at MIT in which sophomores, juniors and seniors, under the guidance of faculty mentors and instructors, learn, discover, build and engineer living systems for broad applications in biotechnology and medical devices. This webinar will share the perspectives of 3 MIT faculty, their research capabilities and interests in which NEET students can participate, and that of several NEET students and what they can or hope to achieve.
How can small molecules be identified that evoke cell or tissue regeneration by design? How can we engineer cells and tissue-growth in situ with a structure suitable for implantation? How can we physically gain access to the interior of cells for both discovery and engineering purposes? And how can the immune system be mapped with single-cell biology to accelerate discovery?